Published: 26 July 2017
Author(s): Mohammad Reza Emami, Elham Alipoor, Mohammad Javad Hosseinzadeh-Attar
Issue: July 2017
Section: Letter to the Editor

Impaired glucose-insulin homeostasis is a well-described metabolic disorder in chronic kidney disease (CKD) [1]. Early reports, using euglycemic insulin clamp technique, demonstrated the occurrence of insulin resistance in people with chronic hemodialysis (HD) [2]. Kidneys have a pivotal role in insulin metabolism. Impaired renal clearance of insulin, along with other metabolic derangements, result in insulin resistance [1]. Insulin resistance is an independent predictor of mortality from cardiovascular disorders in patients with end stage kidney failure, irrespective of diabetes, age, body mass index (BMI), concomitant hypertension, dyslipidemia, or the concentration of C-reactive protein (CRP) [3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.